Alnylam Pharmaceuticals
company
Funding Round
Post-IPO Equity
Money Raised
$ 10M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Takeda | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jul 7, 2003 | Private Equity（PE） | $ 24.60M | Merck,ARCH Venture Partners | Detail |
